Cited by 787Schizophrenia research and treatmentMental Health and PsychiatryBipolar Disorder and Treatment

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Neuroleptics and the Natural Course of Schizophrenia

Wyatt, R. J.·1991·Schizophrenia Bulletin

Open this paper in CoChat — free account

Abstract

To determine if neuroleptic treatment changes the natural course of schizophrenia, 22 studies were reviewed in which relatively similar patients were or were not given neuroleptics at specific times during the course of their illness. Nineteen of the studies were from first- or predominantly first-break populations. While there was little consensus among the authors of the studies reviewed, a reanalysis of the data indicates that early intervention with neuroleptics in first-break schizophrenic patients increases the likelihood of an improved long-term course. This finding is similar to that of earlier investigators who indicated there was a decrease in patients with the more severe forms of the illness following the introduction of convulsive therapies. Furthermore, there is evidence that stable schizophrenic patients whose neuroleptics are discontinued and have relapses may have a difficult time returning to their previous level of function. The findings describe in this paper have implications for both the treatment of schizophrenia and for understanding the pathophysiological processes that determine the course of the disorder.

Integrity signals

Registry

Crossref · 10.1093/schbul/17.2.325

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,851
International Classification of Diseases, 10th Revision
Tassé, M. J., & Bush, K. (2018) · Sage eBooks · doi:10.4135/9781483392271.n276 · Cited by 1,921
Drug and Family Therapy in the Aftercare of Acute Schizophrenics
Goldstein, M. J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770340019001 · Cited by 521
II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment
Crow, T. J., Macmillan, J. F., Johnson, A. L., & Johnstone, E. C. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.2.120 · Cited by 491
Schizophrenia, just the facts
Wyatt, R. J., Alexander, R., Egan, M. F., & Kirch, D. G. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90034-5 · Cited by 478
Self-citation
Neuropathology of Schizophrenia
Stevens, J. R. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290100011003 · Cited by 474
Longitudinal Studies of Schizophrenic Patients
Huber, G., Gross, G., Schüttler, R., Linz, M. H., & Clemens, S. L. (1980) · Schizophrenia Bulletin · doi:10.1093/schbul/6.4.592 · Cited by 439

Show all 73 references

Sorted by citations

Items 601–700 of 787

INFLUENCE OF PSYCHOTIC EPISODES ON GREY MATTER VOLUME CHANGES IN PATIENTS WITH SCHIZOPHRENIA
Baršić, A. R., Rubeša, G., Mance, D., Miletić, D., Gudelj, L., & Antulov, R. (2020) · Psychiatria Danubina · doi:10.24869/psyd.2020.359 · Cited by 3
Herstel van schizofrenie: een hoopvol perspectief
Wilken, J. P. (2006) · Data Archiving and Networked Services (DANS) · Cited by 3
Course of Schizophrenia: What Has Been Learned from Longitudinal Studies?
Bota, R. G., Munro, S., Nguyen, C. T., & Preda, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-0831-0_11 · Cited by 3
Predictive factors of the number and the dose of anti‐psychotics in a cohort of schizophrenic patients
Lukasiewicz, M., Gasquet, I., Casadebaig, F., Philippe, A., Ledoux, S., Reynaud, M., & Falissard, B. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1189 · Cited by 3
The Efficacy and Safety of Conventional and Atypical Antipsychotics in First-Episode Schizophrenia: A Review of the Literature
Schooler, N. R. (2007) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.1.1.2 · Cited by 3
Long-term studies of antipsychotic drugs in schizophrenia
Lewander, T. (1996) · European Psychiatry · doi:10.1016/0924-9338(96)85177-7 · Cited by 3
The Origin and Course of Schizophrenia: Implications for Clinical Practice
Waddington, J. L., Scully, P. J., QUINN, J. F., Meagher, D. J., & Morgan, M. G. (2001) · Journal of Psychiatric Practice · doi:10.1097/00131746-200107000-00005 · Cited by 3
Preventive strategies for severe mental disorders
Chakrabarti, S. (2017) · Indian Journal of Social Psychiatry · doi:10.4103/ijsp.ijsp_40_17 · Cited by 3
Early Intervention in the Indian Context
Singh, S. P. (2015) · Springer eBooks · doi:10.1007/978-81-322-1674-2_7 · Cited by 3
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
Madera‐McDonough, J., Such, P., Zhao, C. Y., & Baker, R. A. (2019) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s198786 · Cited by 3
Early intervention in psychosis: Perspectives on Asian studies
Venkatasubramanian, G., & Keshavan, M. S. (2012) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2012.02.008 · Cited by 3
Themhs Debate: Who Should be Treated? Burden vs Health Gain
McGorry, P. D. (1997) · Australasian Psychiatry · doi:10.3109/10398569709082283 · Cited by 3
Placebo Studies: Lessons From Psychiatric Research
Manschreck, T. C. (2001) · Psychiatric Annals · doi:10.3928/0048-5713-20010201-11 · Cited by 3
Time for Evaluation of Early Intervention and Prevention in Major Psychiatric Disorders
Addington, D. E. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500401 · Cited by 3
Schizophrenia: Early Intervention
Manchanda, R. (2004) · Cited by 3
Prevalencia de demencias na população de pacientes idosos (>= 60 anos) internados no serviço de saude "Dr. Candido Ferreira" da Prefeitura Municipal de Campinas
Canineu, P. R. (2001) · doi:10.47749/t/unicamp.2001.218751 · Cited by 3
Olanzapine Pamoate Use for Schizophrenia: Retrospective Records Based Study from a Tertiary Care Hospital
Grover, S., Singla, H., Chakrabarti, S., & Avasthi, A. (2019) · Indian Journal of Psychological Medicine · doi:10.4103/ijpsym.ijpsym_269_19 · Cited by 2
Quality of life in patients with schizophrenia
Meher, A. C., Satpathy, S., Supakar, S., & Pradhan, P. C. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns5.9041 · Cited by 2
A new two-hit animal model for schizophrenia research: Consequences on social behavior
Hakenova, K., Mikulecká, A., Holubová, K., Chvojková, M., Šlamberová, R., Jur̀čovičová, J., Čechová, B., Poništ, S., Horáček, J., & Valeš, K. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.012 · Cited by 4
Outcome Study of Early Onset Schizophrenia.
Esther, E., Jesjeet, S. G., & Hh, A. (2005) · Cited by 2
Convergent and incremental validity of the MMPI -2 and Rorschach on psychotic -related indices
Dao, T. K. (2007) · Cited by 2
Electroconvulsive Therapy: Issues in the Elderly
Das, A., & Chiu, E. (2002) · Psychogeriatrics · doi:10.1111/j.1479-8301.2002.tb00038.x · Cited by 2
The ethics of conducting psychosis-inducing experiments.
Sharav, V. (1999) · Accountability in Research · doi:10.1080/08989629908573948 · Cited by 2
¿Neurodesarrollo o neurodegeneración? Estado actual
Mané, A. (2013) · Psiquiatría Biológica · doi:10.1016/j.psiq.2013.08.001 · Cited by 2
Actualité des données sur les modalités évolutives de la schizophrénie
Simonnot, A., Gluck-Vanlaer, N., Abe, K., Caillat, A., & Auby, P. (2007) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(07)40983-x · Cited by 2
Views and strategies of African-American caregivers of persons with schizophrenia on medication treatment and other supports
Joy, M. T., Kohler, C. G., & Griffith, T. H. (2017) · Qualitative Social Work · doi:10.1177/1473325017718927 · Cited by 2
Medications for Psychosis: Dopamine Blockers and Dopamine Partial Agonists (Antipsychotics)
Uchida, H., Kim, E., Jarskog, L. F., Fleischhacker, W. W., Remington, G. J., & Lieberman, J. A. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_134-1 · Cited by 2
A Cross Sectional Study of Factors Influencing Duration of Untreated Psychosis in a Tertiary Mental Health Care Institute
Nallapaneni, N., Lanka, U. V. R., & Paritala, C. B. G. (2015) · International Journal of Innovative Research and Development · Cited by 2
The effect of baseline antipsychotic status on the 12‐month outcome in initially stabilized patients with schizophrenia
Fountoulakis, K. Ν., Panagiotidis, P., & Nimatoudis, I. (2019) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2712 · Cited by 2
Assessment of Real-Life Outcomes in Schizophrenia Patients according to Compliance
Qureshi, Z. P., Khandker, R. K., Shepherd, J., Samant, S., Chekani, F., & Bailey, H. M. L. (2020) · Psychiatry Journal · doi:10.1155/2020/5848601 · Cited by 2
(Potentielle) Antipsychotika mit neuartigen Wirkmechanismen
Kasper, S. F. (1998) · Springer eBooks · doi:10.1007/978-3-7091-6458-7_9 · Cited by 2
First episode research
Yung, A. R. (1998) · Current Opinion in Psychiatry · doi:10.1097/00001504-199801000-00015 · Cited by 2
Low prevalence of age disorientation in Dutch long-stay patients
Selten, J., & Cath, D. C. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)00049-e · Cited by 2
The use of psychopharmacological and other treatments by persons with psychosis
Morgan, V. A., Low Prevalence Disorders Study Group, Castle, D. J., & Jablensky, A. V. (2002) · PsycEXTRA Dataset · doi:10.1037/e677362010-001 · Cited by 2
Chronic schizophrenia
Pary, R., TOBIAS, C. R., & Lippmann, S. (1995) · Postgraduate Medicine · doi:10.1080/00325481.1995.11946077 · Cited by 2
Pharmacological Treatment
Sherin, J. E., & Marder, S. R. (2011) · doi:10.1002/9780470978672.ch6 · Cited by 2
INFLUENCE OF DURATION OF UNTREATED PSYCHOSIS ON THE SHORT-TERM OUTCOME IN FIRST-EPISODE SCHIZOPHRENIA
K, B., Pugazhendhi, K., BALAMURUGAN, K., & Punithavathi, D. (2024) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2024.v17i5.50217 · Cited by 1
Attitudes of Italian psychiatrists towards the use of Long-Acting Injectable antipsychotics in the management of schizophrenia relapse: insights from the ALIA study
Giorgio, A. D., Massaro, A., Bergamelli, E., Libri, C., Bondi, E., & Canali, M. E. (2025) · Schizophrenia Research · doi:10.1016/j.schres.2025.09.014 · Cited by 1
The duration of active psychosis and relationship with early psychosis outcomes
Crowley, P., Boland, F., Thompson, A., McGorry, P. D., O'Donoghue, B. N., & Lyne, J. (2026) · Schizophrenia Research · doi:10.1016/j.schres.2026.03.014 · Cited by 1
Effects of antipsychotics, vitamin E, and MK-801 on dopamine dynamics in the rat brain following discontinuation of cocaine
Wyatt, R. J., Karoum, F., & Masserano, J. M. (1998) · Psychiatry Research · doi:10.1016/s0165-1781(98)00080-8 · Cited by 1
Self-citation
Longitudinal Course of Schizophrenia
Bota, R. G., & Preda, A. (2011) · Current Psychiatry Reviews · doi:10.2174/157340011797183157 · Cited by 1
Modal Developmental Aspects of Schizophrenia Across the Life Span
Walker, E. F., Davis, D., Weinstein, J. A., Savoie, T. M., Grimes, K., & Baum, K. M. (1995) · Series in psychopathology · doi:10.1007/978-1-4612-4234-5_4 · Cited by 1
Medication treatment for anxiety, depression, schizophrenia, and bipolar disorder in the community setting
Shaywitz, J., & Marder, S. R. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780199565498.003.0109 · Cited by 1
The ethics of early identification and intervention in psychosis
Marriott, C., & Broome, M. R. (2019) · Developments in neuroethics and bioethics · doi:10.1016/bs.dnb.2019.05.003 · Cited by 1
Mental Health Retrosight: Case studies
Pollitt, A., Diepeveen, S., Guthrie, S., Morgan Jones, M., Ni Chonaill, S., Olmsted, S. S., Schultz, D., Pincus, H. A., Grant, J., & Wooding, S. (2013) · RAND Corporation eBooks · doi:10.7249/rr452 · Cited by 1
The impact of antipsychotic side-effects on attitudes toward medication in patients with schizophrenia and related disorders: a systematic review
Ling, C. Y., Klainin‐Yobas, P., & Ignacio, J. (2011) · JBI Library of Systematic Reviews · doi:10.11124/jbisrir-2011-140 · Cited by 1
Medication adherence in schizophrenia: The role of family supervision, dosage frequency and medication knowledge
Jombo, H. E., & Abasiubong, F. (2015) · Ibom Medical Journal · doi:10.61386/imj.v8i2.127 · Cited by 1
Over 30 years of STEP : The Pittsburgh experience with first‐episode psychosis
Wood, H. J., Jones, N., Eack, S. M., Chengappa, K. N. R., Prasad, K. M. R., Kelly, C., Montrose, D. M., Schooler, N. R., Ganguli, R., Carter, C. S., et al. (2024) · Early Intervention in Psychiatry · doi:10.1111/eip.13536 · Cited by 1
Chapter 15. Role of Aerobic Exercise in the Treatment of Early Psychosis
Ospina, L. H., Ballon, J. S., & Kimhy, D. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379217.lg15 · Cited by 1
Dopamine and the Biology and Course of Treatment Resistance
Demjaha, A., & Howes, O. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-45257-4_3 · Cited by 1
Early intervention for incipient insanity: early notions from the 19th century English literature
Chau, H. S., Chong, W.-S., Wong, J., Hung, G. B. K., Lui, S. S. Y., Chan, S. K. W., Chang, W. C., Hui, C. L. M., Lee, E. H. M., McGorry, P. D., et al. (2016) · Early Intervention in Psychiatry · doi:10.1111/eip.12355 · Cited by 1
Psyche, Schmerz, sexuelle Dysfunktion
(2003) · Springer eBooks · doi:10.1007/978-3-642-55608-1 · Cited by 1
Preparation and Characterization of Intramuscular PLGA Based Microsphere
Pathak, P., & Paliwal, S. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i5.3631 · Cited by 1
Mad science: discourses of 'schizophrenia'and 'therapy' for hearing voices
Wise, M. J. (2004) · Murdoch University Research Portal · Cited by 1
Langzeitbehandlung schizophrener Erkrankungen: Konzept, Methoden, Strategien
Gäebel, W. (1998) · Springer eBooks · doi:10.1007/978-3-7091-6471-6_25 · Cited by 1
Diagnosis, Neurobiology, and Treatment of First-episode Schizophrenia
Jarboe, K. S., & Kilts, C. D. (1998) · Journal of the American Psychiatric Nurses Association · doi:10.1016/s1078-3903(98)90025-8 · Cited by 1
Health gain in schizophrenia: Current themes in theory and practice
Thomas, P. (1993) · Journal of Mental Health · doi:10.3109/09638239309016952 · Cited by 1
Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
Lee, P., Kim, C. E., Kim, C. Y., Lin, W., Habil, H., Dyachkova, Y., Mcbride, M., & Dossenbach, M. R. K. (2008) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500801976634 · Cited by 2
New Developments in the Pharmacologic Treatment of Schizophrenia: Editor's Introduction
Kane, J. M. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.2.193 · Cited by 1
Outpatient Care in Schizophrenia
Meise, U., Wulf Rössler, A., & Fleischhacker, W. W. (1994) · CNS Drugs · doi:10.2165/00023210-199401040-00003 · Cited by 1
Atypische Neuroleptika: Compliance und Lebensqualität
Naber, D., & Lambert, M. (1999) · Steinkopff eBooks · doi:10.1007/978-3-642-93709-5_1 · Cited by 1
The schizophrenia prodrome: promise for prevention
Cornblatt, B. (2001) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2001.3.2/bcornblatt · Cited by 10
Developmental models and hypothesis-driven early interventions in schizophrenia
Keshavan, M. S., & Cornblatt, B. A. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103.026 · Cited by 1
The use of adjuvant L-arginine in schizophrenia: A behavioural and neurochemical analysis
MacKay, M.-A. B. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3zs2kq4m · Cited by 1
Traditional Methodology and Outcome Assessment in Studies on the Course of Schizophrenia
Riecher‐Rössler, A. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4147-9_30 · Cited by 1
Antipsychotic medication for early episode schizophrenia
Bola, J. R., & Soydan, H. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006374 · Cited by 1
Schizophrenia and Related Psychoses
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg001.pub2 · Cited by 2
Characteristics, course and outcome in first-episode psychosis : a cross-cultural comparison of Finnish and Spanish patient groups
Kalla, O. (2005) · Jyväskylä University Digital Archive (University of Jyväskylä) · Cited by 1
Biopsychosocial predictors of paranoia in the attenuated psychosis syndrome
Shaikh, M. (2014) · Royal Holloway Digital Repository (Royal Holloway University of London) · Cited by 1
Neue Ansätze zur Früherkennung und Frühbehandlung schizophrener Störungen
Klosterkötter, J. (1998) · Springer eBooks · doi:10.1007/978-3-642-72204-2_3 · Cited by 1
Clinical predictors in young help-seeking people referred to the Lancashire Early Assessment and Detection Clinic : a service evaluation
Johnson, C. (2013) · Research Explorer (The University of Manchester) · Cited by 1
Progressive Brain Volume Changes and the Clinical Course of Schizophrenia in Men: A Longitudinal Magnetic Resonance Imaging Study
Mathalon, D. H., Sullivan, E. V., Lim, K. O., & Pfefferbaum, A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.2.148
First episode psychosis and psychological development in young adulthood
McEachran, A. K. (2006) · Summit (Simon Fraser University)
Le Case Management
Gosset, C., & Dejace, A. (1997)
Stellenwert und Grenzen klassischer Neuroleptika in der Langzeittherapie schizophrener Erkrankungen
Gäebel, W., & Jänner, M. (1998) · Springer eBooks · doi:10.1007/978-3-642-72152-6_6
Grundlagen und Strategien neuroleptischer Rezidivprophylaxe — unter besonderer Berücksichtigung der neuroleptischen Intervallbehandlung
Gäebel, W. (1995) · Springer eBooks · doi:10.1007/978-3-642-93565-7_6
The impact of antipsychotic side effects on attitudes toward medication in patients with schizophrenia: A systematic review
Ling, C. Y., Klainin, P., & Ignacio, J. (2009) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/01938924-200907241-00010
Anticorps anti-récepteur NMDA dans les premiers épisodes psychotiques
Guen, E. L. (2014) · HAL
Clients' and carers' experiences of an Early Intervention for Psychosis Service
Woolley, J. (2012) · ORCA Online Research @Cardiff (Cardiff University)
The impact of antipsychotic side-effects on attitudes toward medication in patients with schizophrenia and related disorders: a systematic review
Ling, C. Y., Klainin‐Yobas, P., & Ignacio, J. (2011) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/01938924-201109220-00001
Molecular Medicine and the Prospects for Prevention and Early Intervention in Schizophrenia
Carpenter, W. T., & Koenig, J. I. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-729-1_17
Intervention i præpsykotiske tilstande: En gennemgang af aktuel forskning og relaterede problemstillinger
Olsen, K. A., & Rosenbaum, B. (2004) · Nordisk Psykologi · doi:10.1080/00291463.2004.10637443
Prediction of drug responses in schizophrenia: A method using a test dose of chlorpromazine
MINAMI, H., Nakahara, T., MIYAHARA, A., & Nakane, Y. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02586.x
Are All Neuroleptics Equal, Or Are Some More Equal Than Others?
Flowers, C. J., & Simpson, G. M. (1997) · Psychiatric Annals · doi:10.3928/0048-5713-19970301-17
On giving up on the mental health system
Johnson, D. L. (2000) · New Directions for Mental Health Services · doi:10.1002/yd.23320008805
La visione di Jung sulle cause e il trattamento della schizofrenia alla luce delle attuali conoscenze delle neuroscienze cognitive e della ricerca in psicoterapia. I. Eziologia e fenomenologia
Silverstein, S. M. (2015) · STUDI JUNGHIANI · doi:10.3280/jun2014-040003
Les rechutes dans la schizophrénie ; comment prévenir?
Messaoudi, A., Seklaoui, S., & Ziri, A. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2014.09.041
Review Article The promise of early intervention
Addington, J. (2007)
Pharmacological treatment of the newly diagnosed patient with schizophrenia
Travis, M. J., & Kerwin, R. W. (1997) · Advances in Psychiatric Treatment · doi:10.1192/apt.3.6.331
Estudi de les determinacions d'àcid homavanílic en plasma i proves atencionals com a factors pronòstic a l'esquizofrènia
Pertegaz, I. B. (2006) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
follow-up study of first-episode schizophrenia Duration of untreated psychosis and social function: 1-year
Joyce, M. A., Barnes, T. R. E., Leeson, V. C., Mutsatsa, S. H., Watt, H., & Hutton, S. B. (2012)
Análise comparativa dos Estilos de Vida, Capacidade Funcional e Qualidade de Vida de pessoas diagnosticadas com esquizofrenia em função do contexto de inserção.
de Oliveira, E. A. (2011)
Critical period and duration of untreated psychosis
Zaytseva, Y. (2011) · Cutting Edge Psychiatry in Practice · doi:10.65031/czfc2554
Brain MRI in subjects with schizophrenia and in adults born prematurely : the Northern Finland 1966 Birth Cohort Study
Tanskanen, P. (2010)
Psychiatric and neurological symptoms in schizophrenia and substance use disorder patients treated for 12-weeks with quetiapine
Zhornitsky, S. (2012) · doi:10.71781/27228
MICROSTRUCTURAL CHANGES IN FRONTAL WHITE MATTER ASSOCIATED WITH CANNABIS USE IN EARLY PHASE PSYCHOSIS: A DIFFUSION TENSOR IMAGING (DTI) STUDY
Cookey, J. (2016) · DalSpace (Dalhousie University)
Antipsychotic drug utilization patterns and treatment -emergent diabetes: A methodological comparison of incidence using a claims database
Yang, M. S. (2006) · Texas ScholarWorks (Texas Digital Library)
Untersuchung der LTP-artigen Plastizität über dem linken M1 nach anodaler tDCS bei Patienten mit einer Schizophrenie
Rein, B. (2015) · doi:10.53846/goediss-5228
Studying chemical and electrical neuronal dynamics as a platform for understanding schizophrenia
Das, T. K., Rajakumar, N., & Jog, M. (2013) · Journal of Coupled Systems and Multiscale Dynamics · doi:10.1166/jcsmd.2013.1029
L'approccio epidemiologico nella valutazione della terapia farmacologica in psichiatria
Bellantuono, C. (1993) · Epidemiologia e Psichiatria Sociale · doi:10.1017/s1121189x00006953

Authors: Wyatt, R. J.
Affiliations: St. Elizabeths Hospital (US)
Corresponding author: Wyatt, R. J.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 1991-01-01
Volume: 17
Issue: 2
Pages: 325-351
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/schbul/17.2.325
OpenAlex: W2120012268
Cited by: 787
References: 73
Citations by year: 2026: 6 · 2025: 10 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 21 · 2020: 12 · 2019: 48 · 2018: 14 · 2017: 18 · 2016: 17 · 2015: 17 · 2014: 18 · 2013: 22 · 2012: 27
FWCI: 13.18
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: schizophrenia, antipsychotic drugs
MeSH terms: Humans, Recurrence, Schizophrenia, Time Factors, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroleptics and the Natural Course of Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks